6th Edition – Versions – Global research collaboration for infectious disease preparednessGLOPID-R

Canadian Institutes of Health Research (CIHR)

Canada

Represented by Charu Kaushic

Medical Research Council (MRC)

United Kingdom

Represented by Anna Kinsey

National Research and Innovation Fund for Development (FONRID)

Burkina Faso

Represented by Hamidou H. Tamboura

African Academy of Sciences (AAS)

Kenya

Represented by Thomas Kariuki

Indian Council of Medical Research (ICMR)

India

Represented by Samiran Panda

Coalition for Epidemic Preparedness Innovations (CEPI)

Observer

Represented by Richard Hatchett & Frederik Kristensen

Fund for Science, Technology and Innovation (FONSTI)

Cote d’Ivoire

Represented by Annette Ouattara

European Commission – DG Research & Innovation

European Commission

Represented by Barbara Kerstiens

ANRS | Emerging Infectious Diseases

France

Represented by Yazdan Yazdanpanah

South African Medical Research Council

South Africa

Represented by Jeffrey Mphahlele

Wellcome Trust

United Kingdom

Represented by Jeremy Farrar

Japan Agency for Medical Research and Development (AMED)

Japan

Represented by Shoji Miyagawa

UK Department of Health & Social Care

United Kingdom

Represented by Lucy Chappell

Sao Paulo Research Foundation (FAPESP)

Brazil

Represented by Reinaldo Salomao

Ministry of Health

Italy

Represented by Gaetano Guglielmi

National Council for Science and Technology (NCST)

Rwanda

Represented by Eugene Mutimura

German Federal Ministry of Education and Research (BMBF) / PT-DLR

Germany

Represented by Manuela Rehtanz

European & Developing Countries Clinical Trials Partnership (EDCTP)

Observer

Represented by Pauline Beattie

Research Council of Norway (RCN)

Norway

Represented by Thomas Hansteen

National Institute of Health Carlos III (ISCIII)

Spain

Represented by Tomás López-Peña

National Institute of Health, Department of Medical Sciences

Thailand

Represented by Aree Thattiyaphong

Gavi, the Vaccine Alliance

Observer

Represented by Marta Tufet-Bayona

ESSENCE on Health Research Initiative Secretariat (WHO/TDR)

Observer

Represented by Garry Aslanyan

Secretariat of Government of Science, Technology and Productive Innovation

Argentina

Represented by Diego Galeano

World Health Organization (WHO)

Observer

Represented by Ana-Maria Henao-Restrepo

Netherlands Organisation for Health research and Development (ZonMw)

Netherlands

Represented by Suzanne Verver

Bill & Melinda Gates Foundation

USA

Represented by David W. Vaughn

National Health & Medical Research Council (NHMRC)

Australia

Represented by Anne Kelso

Swiss National Science Foundation (SNSF)

Switzerland

Represented by Matthias Egger

Butantan Institute

Brazil

Represented by Alexander Precioso

Global Outbreak Alert and Response Network (GOARN)

Observer

Represented by Gail Carson

Pasteur Network

France

Represented by Nadia Khelef

International Development Research Centre (IDRC)

Canada

Represented by John Dusabe-Richards

Foreign, Commonwealth & Development Office (FCDO)

United Kingdom

Represented by Jo Mulligan

European Research Infrastructure on Highly Pathogenic Agents (ERINHA)

Observer

Represented by Jonathan Ewbank

National Council of Science and Technology (CONACYT)

Mexico

Represented by Juan José Serrato

Department of Health and Human Services

USA

Represented by Chris Hassell

Academy of Scientific Research & Technology (ASRT)

Egypt

Represented by Amr Radwan

Fiocruz Institute

Brazil

Represented by Marco Krieger

National Research Foundation of Korea

Korea

Represented by Choong-Min Ryu

Canada

United Kingdom

Burkina Faso

Kenya

India

Observer

Cote d’Ivoire

European Commission

France

South Africa

United Kingdom

Japan

United Kingdom

Brazil

Italy

Rwanda

Germany

Observer

Norway

Spain

Thailand

Observer

Observer

Argentina

Observer

Netherlands

USA

Australia

Switzerland

Brazil

Observer

France

Canada

United Kingdom

Observer

Mexico

USA

Egypt

Brazil

Korea

Latest News & Events

Living Mapping Review: New iteration brings crucial insights for future COVID-19 research funding as we move to a post-pandemic world

Upcoming webinar: Response to COVID-19 vaccine in patients with a hematological condition and primary immunodeficiencies

GloPID-R and UK DHSC organise funders’ roundtable to strengthen the clinical trials ecosystem

GloPID-R 2021 Highlights and Season’s Greetings

Resources

COVID-19 Research Project Tracker

ISIDORe Access Call Dedicated To SARS-CoV-2 and COVID-19

Global opportunities to prepare for future pandemics

Our Tracker celebrates 2 years of growth mapping research projects & trends